Comprehensive Transcriptomic Profiling of Diverse Brain Tumor Types Uncovers Complex Structures of the Brain Tumor...

Area of Science:

• Neuro-oncology
• Immunology
• Genomics

Background:

• Brain tumors exhibit diverse characteristics, including malignancy, lineage, location, and genomic profile.
• Immunotherapy, leveraging immune cells within the tumor microenvironment (TME), is a promising brain tumor treatment strategy.

Purpose of the Study:

• To analyze the transcriptomic architecture of the brain TME for potential therapeutic strategies.
• To identify distinct immune cell populations and their relation to brain tumor characteristics.

Main Methods:

• Decomposition of cellular populations in six brain tumor types using microarray and single-cell RNA sequencing (scRNA-seq) data.
• Transcriptome-based immune cell profiling and unsupervised clustering using immune-related genes.
• Analysis of immune subpopulation responses to anti-PD-1 therapy in glioblastoma.

Main Results:

• Distinct infiltrating immune cell types (M2 macrophages, CD8+ T cells, CD4+ T cells) were identified and varied by tumor type, malignancy, and location.
• scRNA-seq showed differences in dendritic and mural cell proportions.
• Unsupervised clustering revealed two distinct sample clusters based on immune-related genes, with varied responses to anti-PD-1 therapy.

Conclusions:

• The study provides a transcriptomic landscape of the distinct TME across brain tumor types.
• Findings offer a rationale for precision medicine and improved therapeutics for brain tumors, potentially overcoming treatment vulnerabilities.